We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fluorescence Analyzers Evaluated for Diagnoses of UTIs

By LabMedica International staff writers
Posted on 10 Sep 2018
Urinary tract infections (UTIs) are among the most frequent infections in both hospitalized and outpatients. More...
As a result, urine specimens constitute a significant proportion of routine microbiology laboratory workload.

Traditional culture remains the “gold standard” for the diagnostic evaluation of patients suspected of having a UTI as it allows the identification of the etiological agents, to estimate the concentration of isolated microorganisms and to offer susceptibility testing for targeting the optimal antibiotic therapy.

Medical microbiologists at the Pordenone Hub Hospital (Pordenone, Italy) evaluated 2,719 midstream urine samples from 1,198 (44.1%) male and 1,521 (55.9%) female, aged from 0 and 97 years (median age = 66 years), submitted to the microbiology laboratory with a specific request for urine culture. Inpatients were 23.9% and outpatients 76.1%. The study was conducted from April 6 to June 12, 2017.

All specimens that passed an exclusion criterion were analyzed with the Sysmex UF-5000 (Sysmex Corporation, Kobe, Japan). The analyzer can discriminate and count 17 diagnostic parameters of cells and formed elements in urine and offers an integrated body fluid mode (BF), available on the instrument with a switch, which can classify and count seven diagnostic parameters. The system employs fluorescence flow cytometry technology, using a new blue semi-conductor laser at 488 nm wavelength, Gram staining of centrifuged specimens was conducted in case of discrepancies between the results of the UF-5000 Bact Info flag and the culture method.

The scientists reported that of the 2,719 samples, 1,922 (70.7%) were negative in urine culture (sterile or ≤ 104 CFU/mL) and 797 (29.3%) showed significant growth. In 574 of the positive samples a single microorganism was identified, in 71 samples two microorganisms were isolated, and 152 samples showed mixed flora. The microorganisms isolated reflected the usual rate of uropathogens in their laboratory, so that the most frequent bacteria reported were Gram negatives accounting for 76.9% of all species isolated, and the majority were Enterobacteriaceae. The UF-5000 showed a very good performance in the screening process. Carryover and cross-contamination was negligible and 797 samples were culture positive at a cut-off of ≥105CFU/mL.

The authors concluded that the new Sysmex UF-5000 showed high diagnostic accuracy in UTI-screening with a very low rate of false negatives. The instrument is capable of predicting Gram negatives with a good standard error and a high agreement with the culture, even if this performance needs further evaluation. The study was published in the September 2018 issue of the journal Clinica Chimica Acta.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Thyroid Test
Anti-Thyroid EIA Test
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

Predicting which patients with early-stage breast cancer will develop distant recurrence remains difficult, complicating decisions about long-term therapy and surveillance. Widely used genomic assays are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.